ArticleLeukemia research2021

Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia.

Hetty E Carraway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.